SEC Filing Summary: CVS HEALTH Corp (13F-HR)
Business Context and Reporting Period
This filing is a Form 13F-HR (Holdings Report) submitted by CVS HEALTH Corp, acting as an Institutional Investment Manager. The report covers the quarter ended March 31, 2026. The filing was signed by Michael Motolo, Executive Director, on May 7, 2026.
Key Financial Metrics
As a Form 13F filing, this document reports investment holdings rather than the company's operational financial performance (e.g., revenue, profit, or cash flow). The filing provides the following aggregate data regarding the manager's reported portfolio:
- Total Value of Reported Holdings: $212,255,190
- Total Number of Holdings Entries: 33
- Number of Other Included Managers: 0
Note: The filing text does not provide clear values for CVS Health Corp's own revenue, profit, margins, debt, or liquidity, as this form is designed to disclose equity positions held by the manager, not the manager's corporate financial statements.
Material Changes
The filing text does not provide comparative data for the prior period (e.g., December 31, 2025) to determine material changes in holdings value or composition. The document is a standalone snapshot of holdings as of the reporting date.
Guidance, Outlook, and Risks
This filing type does not contain management commentary, forward-looking guidance, risk factors, or contingencies regarding the business operations of CVS Health Corp. It strictly lists securities held for investment purposes.
Key Facts for Investor Verification
- Verify the specific list of 33 equity holdings to understand the investment strategy of CVS Health Corp's investment arm.
- Confirm that the total reported value of $212.26 million represents only the specific subset of holdings required to be reported under Section 13(f) of the Exchange Act.
- Note that this filing does not reflect the broader financial health or operational results of CVS Health Corp as a public company; refer to Form 10-Q or 10-K for those metrics.